In an interview with @medcitynews, Bill Martin, the Global Therapeutic Area Head of Neuroscience at The Janssen Pharmaceutical Companies of $JNJ, shared some of the promising developments in the neuroscience space  [Sponsored by Johnson &amp; Johnson]